|Trial status||Trial open for recruitment|
Interventional with experimental drug
|Phase||Trial phase 1/2|
|Inclusion criteria||Locally-advanced or metastatic malignancy with : KRAS p.G12Cmutation|
The New Jules Bordet Institute, located on the university campus of the ULB in Anderlecht, is ready and will soon welcome its first patients. A new state-of-the-art hospital entirely dedicated to the fight against cancer.